Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre Giguère

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MD

Global HIV Clinical Forum 2018

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma

INTEREST 2016

Levels and durability of humoral and T-specific responses after the booster dose of mRNA BNT162b2 vaccine in residents of a Long Term Care Facility

European Meeting on HIV & Hepatitis 2022

Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network

European Meeting on HIV & Hepatitis 2021

Clinical Case presentation- Chien-Ching Hung, MD, PhD

APACC 2017

Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies

European Meeting on HIV & Hepatitis 2022

Epidemiological and clinical features of SARS-CoV-2 variants circulating between April- December 2021 in Italy

European Meeting on HIV & Hepatitis 2022

Creation of an Italian HIV DNA Network for the validation and clinical use of HIV-1 DNA quantification assays

European Meeting on HIV & Hepatitis 2020

Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database

European Meeting on HIV & Hepatitis 2020